People living with and at risk of tuberculosis (TB) call for better access to the long-awaited shorter, less toxic TB treatment regimens. Due to the intense renewed investments over the past two decades, it is possible to treat TB infections in as little as one month and most forms of drug-sensitive and drug-resistant TB in four and six months respectively. However, these options fall short if not able to reach the people who are suffering from TB, which is the focus of the 1/4/6x24 campaign, launched at the AIDS 2022 conference in Montreal
Latest resources from the 1/4/6 x 24 campaign
New publication in Nature Medicine Campaign partners outline the importance of the 1/4/6 x 24 campaign and call for action from key stakeholders to secure the rights of people with and at risk of TB.
Treatment Action Group (TAG) with input from members of the 1/4/6×24 Campaign Coordinating Coalition has developed campaign materials to equip civil society and community based organizations with the information they need to advocate for the campaign.
As countries prepare new funding requests for the upcoming Global Fund grant cycle, this advocacy guide from Global Fund Advocacy Network (GFAN) is an important tool to elevate rapid adoption and roll out of safer, shorter, and more effective novel TB treatment regimens throughout the country dialogue consultation process.
In December 2022, Viatris, a global healthcare company, MedAccess, and TB Alliance have announced a new agreement to reduce the price of pretomanid, a drug used to treat multidrug-resistant tuberculosis, by 34%.
Look out for information on the non-enforcement of secondary patents on bedaquiline in India. The patent hearing in India will take place next Tuesday the 17th, which deserves attention from TB advocates and journalists globally, but particularly those based in India.
Upcoming events of the campaign
TBPPM Discussion: private providers in 1/4/6x24 campaign
Please join us for a Friday Forum/ Webinar discussing the engagement of private providers in the 1/4/6x24 campaign. How can private healthcare providers have better access to shorter TB regimens? What are current barriers? Register and join with your questions and comments!
View details on the TBPPM Friday Forum held in August 2022 discussing the campaign with perspectives from TB survivors, TB program managers, community and advocates.
